Exelixis (EXEL) Assets Average (2011 - 2026)
Exelixis' (EXEL) quarterly Assets Average came in at $2.7 billion in Q2 2026, down 6.0% year-on-year from $2.9 billion in Q2 2025, and down 4.06% quarter-over-quarter from $2.8 billion in Q1 2026.
Exelixis (EXEL) Assets Average (2011 - 2026) Analysis & Trends
Exelixis' Assets Average history runs 16 years deep, the most recent figure standing at $2.7 billion for Q2 2026.
- On a quarterly basis, Assets Average fell 6.0% year-over-year to $2.7 billion in Q2 2026; TTM through Apr 2026 was $2.7 billion, a 6.0% decrease from a year earlier, with the FY2026 full-year figure at $2.9 billion, down 1.66% from the prior year.
- Assets Average retreated to $2.7 billion in Q2 2026 per EXEL's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Assets Average topped out at $3.1 billion in Q2 2023 and bottomed at $2.6 billion in Q2 2022.
- The 5-year median for Assets Average is $2.9 billion (2024), against an average of $2.9 billion.
- Across the five-year window, Assets Average gained 21.78% in 2022 and fell 11.28% in 2024, its largest moves.
- Year by year, Assets Average stood at $3.0 billion in 2022, then decreased by 1.88% to $3.0 billion in 2023, then declined by 3.14% to $2.9 billion in 2024, then fell by 4.04% to $2.8 billion in 2025, then fell by 1.16% to $2.7 billion in 2026.
- Per Business Quant, the three latest EXEL Assets Average figures stand at $2.7 billion (Q2 2026), $2.8 billion (Q1 2026), and $2.8 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 2.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 2.72 Bn |
| Jan 2, 2026 | 2.83 Bn |
| Oct 3, 2025 | 2.75 Bn |
| Jul 4, 2025 | 2.76 Bn |
| Apr 4, 2025 | 2.89 Bn |
| Jan 3, 2025 | 2.95 Bn |
| Sep 27, 2024 | 2.87 Bn |
| Jun 28, 2024 | 2.79 Bn |
| Mar 29, 2024 | 2.87 Bn |
| Dec 29, 2023 | 2.96 Bn |
| Sep 29, 2023 | 3.06 Bn |
| Jun 30, 2023 | 3.14 Bn |
| Mar 31, 2023 | 3.11 Bn |
| Dec 30, 2022 | 3.02 Bn |
| Sep 30, 2022 | 2.92 Bn |
| Jul 1, 2022 | 2.77 Bn |
| Apr 1, 2022 | 2.64 Bn |
| Dec 31, 2021 | 2.53 Bn |
| Oct 1, 2021 | 2.41 Bn |
| Jul 2, 2021 | 2.28 Bn |